These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
421 related items for PubMed ID: 17300840
1. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma. Zhao M, Flynt FL, Hong M, Chen H, Gilbert CA, Briley NT, Bolick SC, Wright KL, Piskurich JF. Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840 [Abstract] [Full Text] [Related]
2. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter. Chen H, Gilbert CA, Hudson JA, Bolick SC, Wright KL, Piskurich JF. Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445 [Abstract] [Full Text] [Related]
3. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, Bolick SC, Wright KL. Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283 [Abstract] [Full Text] [Related]
4. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. O'Keefe GM, Nguyen VT, Ping Tang LL, Benveniste EN. J Immunol; 2001 Feb 15; 166(4):2260-9. PubMed ID: 11160280 [Abstract] [Full Text] [Related]
5. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling. Tooze RM, Stephenson S, Doody GM. J Immunol; 2006 Oct 01; 177(7):4584-93. PubMed ID: 16982896 [Abstract] [Full Text] [Related]
6. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes. Dong Y, Rohn WM, Benveniste EN. J Immunol; 1999 Apr 15; 162(8):4731-9. PubMed ID: 10202014 [Abstract] [Full Text] [Related]
7. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W, Tang LP, Dong Y, Benveniste EN. J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712 [Abstract] [Full Text] [Related]
8. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G. Cell Growth Differ; 2001 Jun 15; 12(6):327-35. PubMed ID: 11432807 [Abstract] [Full Text] [Related]
9. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2. Xi H, Goodwin B, Shepherd AT, Blanck G. Oncogene; 2001 Jul 12; 20(31):4219-27. PubMed ID: 11464288 [Abstract] [Full Text] [Related]
10. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Piskurich JF, Linhoff MW, Wang Y, Ting JP. Mol Cell Biol; 1999 Jan 12; 19(1):431-40. PubMed ID: 9858567 [Abstract] [Full Text] [Related]
11. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA. Tang KC, Trzaska KA, Smirnov SV, Kotenko SV, Schwander SK, Ellner JJ, Rameshwar P. J Immunol; 2008 Feb 01; 180(3):1826-33. PubMed ID: 18209080 [Abstract] [Full Text] [Related]
12. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha. Nikcevich KM, Piskurich JF, Hellendall RP, Wang Y, Ting JP. J Neuroimmunol; 1999 Oct 29; 99(2):195-204. PubMed ID: 10505975 [Abstract] [Full Text] [Related]
13. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes. Lee YJ, Benveniste EN. J Immunol; 1996 Aug 15; 157(4):1559-68. PubMed ID: 8759739 [Abstract] [Full Text] [Related]
14. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. Lu HT, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM. J Exp Med; 1995 Nov 01; 182(5):1517-25. PubMed ID: 7595221 [Abstract] [Full Text] [Related]
15. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. Soos JM, Krieger JI, Stüve O, King CL, Patarroyo JC, Aldape K, Wosik K, Slavin AJ, Nelson PA, Antel JP, Zamvil SS. Glia; 2001 Dec 01; 36(3):391-405. PubMed ID: 11746775 [Abstract] [Full Text] [Related]
16. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells. Ghosh N, Gyory I, Wright G, Wood J, Wright KL. J Biol Chem; 2001 May 04; 276(18):15264-8. PubMed ID: 11279146 [Abstract] [Full Text] [Related]
17. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells. Rahat MA, Chernichovski I, Lahat N. Int Immunol; 2001 Nov 04; 13(11):1423-32. PubMed ID: 11675374 [Abstract] [Full Text] [Related]
18. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP. J Immunol; 1998 Jan 01; 160(1):233-40. PubMed ID: 9551976 [Abstract] [Full Text] [Related]
19. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. Giroux M, Schmidt M, Descoteaux A. J Immunol; 2003 Oct 15; 171(8):4187-94. PubMed ID: 14530341 [Abstract] [Full Text] [Related]
20. Differential usage of class II transactivator promoters PI and PIV during inflammation and injury in kidney. Takeuchi O, Sims TN, Takei Y, Ramassar V, Famulski KS, Halloran PF. J Am Soc Nephrol; 2003 Nov 15; 14(11):2823-32. PubMed ID: 14569092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]